Ocular surface and tear film

The "ocular surface and tear film" comprise the interface between the environment and the anterior segment of the eye, consisting of the corneal and conjunctival surfaces covered by a multilayered tear film (lipid, aqueous, mucin layers). The tear film ensures lubrication, optical quality, antimicrobial defense, epithelial homeostasis, and removal of debris. Dysfunction leads to dry eye disease, which can result in discomfort, visual disturbance, inflammation, and increased risk of infection. The tear film is maintained by complex interactions of glands (meibomian, lacrimal, goblet cells) and neural control, with its integrity essential for eye health and vision. Essential context: - The "tear film" is a biologically essential, multilayered extracellular fluid but is not itself a protein, receptor, or therapeutic molecular target. - The "ocular surface" refers to corneal and conjunctival epithelia, also not a single molecular structure. - Therapeutic interventions target diseases of this unit (e.g., dry eye, infection), often by modulating tear film composition, stability, production, or inflammation, not by binding to a specific molecular target. - Key proteins within the tear film (lysozyme, lactoferrin, lipocalin, secretory immunoglobulin A) are sometimes considered targets for modulating antimicrobial or lubricating functions but are not the same as "ocular surface and tear film" as an entity. Summary judgment for further structuring: This term is *not* a valid molecular target for purposes such as drug interaction or molecular pharmacology. If you wish to target components of the tear film or ocular surface, specify the molecule (e.g., "meibomian gland lipid layer," "lacrimal gland," or individual tear proteins such as "lysozyme").

Other names

Ocular surfaceTear filmOcular surface and tear film unit